Special Issue "New Cancer and Osteoporosis Therapies and Osteonecrosis of the Jaws, Volume Ⅱ"
A special issue of Dentistry Journal (ISSN 2304-6767).
Deadline for manuscript submissions: closed (31 October 2018).
Interests: bisphosphonate associated osteonecrosis; osteomyelitis; squamous cell carcinoma; traumatology; implantology; bisphosphonate; RankL
Special Issues, Collections and Topics in MDPI journals
More than 10 years ago, bisphosphonate-associated osteonecrosis was described for the first time, opening a new research field describing epidemiologic and patho-etiologic data, as well as prevention, diagnostic, and therapy regimes for this new disease. In 2006, more than 150 articles on this topic were published, and since 2009 more than 200 new articles have been listed in PubMed each year, showing the progress of research in this area. In recent years, new active ingredients have been developed and implemented into anti-cancer and osteoporosis therapy, such as RankL inhibitors and tyrosine kinase inhibitors, which lead to osteonecrosis as well.
This Special Issue is interested in all aspects of all dental specialties dealing with this topic. In addition to basic research regarding pathology, prevention, and treatment, clinical topics are of interest. How is dental treatment affected by anti-resorptive therapies, e.g., surgical procedures (tooth extractions, implantology, etc.), periodontal, orthodontic, or endodontic treatment?
Dr. Christian Walter
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Dentistry Journal is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Medication associated/related/induced osteonecrosis of the jaws
- RankL inhibitor
- Tyrosine kinase inhibitors
- VEGF inhibitors
- Prevalence and incidence
- Etiology and pathology
- Microbiological factors
- Influence of bisphosphonates/medication on the bone
- Influence of bisphosphonates/medication on the immune system
- Influence of bisphosphonates/medication on soft tissues
- Risk factors
- Periodontal treatment
- Dental implants
- Orthodontic treatment
- Animal models